97 related articles for article (PubMed ID: 1851578)
1. Radiotherapy plus lonidamine in non-small cell lung cancer.
Cionini L
Semin Oncol; 1991 Apr; 18(2 Suppl 4):49-52. PubMed ID: 1851578
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized comparison of radiation therapy plus lonidamine versus radiation therapy plus placebo as initial treatment of clinically localized but nonresectable nonsmall cell lung cancer.
Scarantino CW; McCunniff AJ; Evans G; Young CW; Paggiarino DA
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):999-1004. PubMed ID: 8083102
[TBL] [Abstract][Full Text] [Related]
3. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors.
Di Cosimo S; Ferretti G; Papaldo P; Carlini P; Fabi A; Cognetti F
Drugs Today (Barc); 2003 Mar; 39(3):157-74. PubMed ID: 12730701
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial with and without lonidamine in non-small cell lung cancer.
Gatzemeier U; Cavalli F; Häussinger K; Kaukel E; Koschel G; Martinelli G; Neuhauss R; von Pawel J
Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
Filipazzi V; Cattaneo MT; Rho B; Frontini L; D'Adda D; Isa L; Scapaticci R; Legnani W; Calzavara MP; Berni F
Oncology; 1993; 50(1):10-3. PubMed ID: 8380632
[TBL] [Abstract][Full Text] [Related]
6. Clinical study and pharmacokinetics of lonidamine in advanced non-small cell lung cancer.
Jones AL; Hardy JR; Newell DR; Smith IE
Eur J Cancer; 1991; 27(4):519. PubMed ID: 1851622
[No Abstract] [Full Text] [Related]
7. Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
Scagliotti GV; Gozzelino F; Albera C; Pescetti G
Chemotherapy; 1989; 35(1):64-8. PubMed ID: 2541978
[TBL] [Abstract][Full Text] [Related]
8. Lonidamine versus polychemotherapy in advanced non-small-cell lung cancer. A preliminary analysis.
Giaccone G; Bagatella M; Donadio M; Bonardi G; Maestroni F; Calciati A
Tumori; 1989 Feb; 75(1):43-6. PubMed ID: 2540581
[TBL] [Abstract][Full Text] [Related]
9. Lonidamine in non-small-cell lung cancer: a phase II study.
Contu A; Olmeo NA; Pani P; Deriu A; Ortu S; Paga C
Tumori; 1991 Feb; 77(1):52-5. PubMed ID: 1850177
[TBL] [Abstract][Full Text] [Related]
10. A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer.
Cakir S; Egehan I
Lung Cancer; 2004 Mar; 43(3):309-16. PubMed ID: 15165089
[TBL] [Abstract][Full Text] [Related]
11. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
12. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
Privitera G; Ciottoli GB; Patanè C; Palmucci T; Tafuri G; Marletta F; De Luca B; Magnani F; De Gregorio M; Greco S
Radiother Oncol; 1987 Dec; 10(4):285-90. PubMed ID: 3444905
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of oral lonidamine in breast and lung cancer patients.
Newell DR; Mansi J; Hardy J; Button D; Jenns K; Smith IE; Picollo R; Catanese B
Semin Oncol; 1991 Apr; 18(2 Suppl 4):11-7. PubMed ID: 2031191
[TBL] [Abstract][Full Text] [Related]
14. The combined use of radiation therapy and lonidamine in the treatment of brain metastases.
DeAngelis LM; Currie VE; Kim JH; Krol G; O'Hehir MA; Farag FM; Young CW; Posner JB
J Neurooncol; 1989 Sep; 7(3):241-7. PubMed ID: 2677257
[TBL] [Abstract][Full Text] [Related]
15. Trials of radical radiotherapy versus chemotherapy plus radical radiotherapy in non-small cell lung cancer.
Cullen MH
Semin Oncol; 1994 Jun; 21(3 Suppl 4):34-41. PubMed ID: 8209275
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of lonidamine in non-small cell lung cancer: final report.
Kokron O; Maca S; De Gregorio M; Ciottoli GB
Br J Cancer; 1990 Feb; 61(2):316-8. PubMed ID: 2155644
[TBL] [Abstract][Full Text] [Related]
17. [The recent progress in chemoradiotherapy of lung cancer].
Ogawara M; Kawahara M; Furuse K
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2058-64. PubMed ID: 9388514
[TBL] [Abstract][Full Text] [Related]
18. Single- and multiple dose pharmacokinetics of lonidamine in patients suffering from non-small-cell lung cancer.
Gatzemeier U; Toomes H; Picollo R; Christoffel V; Lücker PW; Ulmer J
Arzneimittelforschung; 1991 Apr; 41(4):436-9. PubMed ID: 1650226
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
Kokron O; Maca S; Scheiner W; De Gregorio M; Ciottoli GB
Oncology; 1984; 41 Suppl 1():86-9. PubMed ID: 6717902
[TBL] [Abstract][Full Text] [Related]
20. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]